BRISBANE: Radformation, a leader in radiation oncology software, and Icon Group, a global provider of cancer care, have announced a strategic partnership to improve treatment planning and quality assurance workflows.

The collaboration will leverage the expertise of both innovators to deliver groundbreaking solutions that simplify and enhance the delivery of personalised cancer treatment.

Radformation’s software, such as AutoContour and RadMachine, uses artificial intelligence and cloud technology to automate and streamline complex tasks, such as contouring and machine QA. This helps radiation oncology teams to save time, reduce errors, and ensure optimal performance of their equipment.

Icon Group, which operates a network of state-of-the-art cancer centres, compounding facilities, research and pharmacy management services, is committed to bringing the best care to as many people as possible, as close to home as possible. Icon Group is often first to market in the latest radiation therapy technologies and treatments.

The partnership aims to empower clinicians to elevate treatment outcomes and patient experiences, and to address the global cancer burden by transforming cancer care.

Trent Aland, Icon Group Executive Manager of Clinical Care, said: “Our partnership with Radformation will enable us to co-develop and implement quality improvement tools by leveraging our collective expertise and skills. Radformation’s tools will support our clinical teams globally and aid in streamlining processes to increase efficiencies and allow us to deliver the best possible care to more people.”

Joe Ianni, VP Global Sales & Strategic Partnerships for Radformation, said: “We are thrilled to partner with Icon. Their global reputation for excellence and commitment to innovation aligns seamlessly with our vision for advancing radiation oncology workflows. Together, we have the opportunity to improve the way cancer treatment is delivered and further empower clinicians in their mission to save lives.”